Pathogenesis Of Enteric Viral Hepatitis

肠道病毒性肝炎的发病机制

基本信息

项目摘要

We have studied the pathogenesis of viral hepatitis and the molecular basis for virulence and attenuation of these important pathogens. We have shown previously that virulence and attenuation of hepatitis A virus (HAV) are controlled principally by two genes: VP1/2A and 2C. However, attenuating mutations are strongly selected against in vivo, resulting in the emergence of virulent variants. This has important implications for the development of live attenuated hepatitis A vaccines. The pathogenesis of hepatitis A is also being studied in the chimpanzee model by microarray analysis. Both innate and adaptive responses have been recorded. Interestingly, HAV does not trigger as robust an up-regulation of certain interferon stimulated genes as HCV and HDV infections. This is surprising because HAV and HCV are both single-stranded RNA viruses with a double-stranded replicative form and HDV is a single-stranded virus with extensive base pairing that is perceived as double-stranded RNA. Specifically, in FY 2009, we compared the innate and adaptive immune responses to HAV infection in several experimentally infected chimpanzees, including animals that received virulent inocula and those that were infected with attenuated strains of HAV. Animals infected with virulent strains had a robust innate immune response (although not as robust as that seen in HCV-infected chimpanzees), whereas the response was less marked in the attenuated infections. Interestingly, innate immune responses were abbreviated in the latter chimpanzees, but detection of the innate immune response was almost as sensitive a diagnostic test of infection as was detection of specific serologic or molecular probes of HAV infection. The adaptive immune responses were also present, but not as robust as the adaptive immune responses in HCV infections of chimpanzees. It will be important to search for viral mechanisms of control that may block some of these systems. Although rare in the United States, hepatitis E is the single most important cause of acute hepatitis among adults throughout Asia, the Middle East and North Africa. Like most of the hepatitis viruses, it replicates poorly or not at all in cell culture and cannot be transmitted to small laboratory animals. We have developed replicons for the study of HEV in vitro; these tools are permitting a detailed molecular analysis of viral replication that can be confirmed in vivo with molecularly engineered infectious cDNA clones of the virus. In addition, with colleagues, we are developing small animal models (swine HEV in swine, avian HEV in chickens) that, with nonhuman primate models of HEV, provide an unprecedented opportunity for studying the comparative pathogenesis of hepatitis E viruses. Finally, hepatitis E has also been studied by microarray and a brisk innate but weak adaptive immune response has been seen. Specifically, in FY 2009, we compared the innate and adaptive immune responses of several chimpanzees to experimental HEV infections with those observed in chimpanzees that had been experimentally infected with HCV or HAV. In comparison with those infections, HEV infections were characterized by an abbreviated and somewhat shortened adaptive immune response. This is particularly interesting in light of other observations that antibody titers tend to diminish more rapidly in HEV infections than in infections with the other hepatitis viruses.
我们研究了病毒性肝炎的发病机制以及这些重要病原体的毒力和衰减的分子基础。我们以前已经表明,甲型肝炎病毒(HAV)的毒力和衰减主要由两个基因控制:VP1/2A和2C。然而,减毒突变在体内被强烈选择,导致毒性变异的出现。这对研制甲型肝炎减毒活疫苗具有重要意义。甲型肝炎的发病机制也正在黑猩猩模型中通过微阵列分析进行研究。先天反应和适应性反应都有记录。有趣的是,甲肝病毒不会像丙肝病毒和丙肝病毒感染那样引发某些干扰素刺激基因的强烈上调。这是令人惊讶的,因为甲肝病毒和丙肝病毒都是具有双链复制形式的单链RNA病毒,而丙肝病毒是具有广泛碱基配对的单链病毒,被认为是双链RNA。具体来说,在2009财政年度,我们比较了几只实验感染的黑猩猩对甲肝病毒感染的先天免疫和适应性免疫反应,包括那些接受了强毒性疫苗接种的动物和那些感染了甲肝病毒减毒株的动物。感染了毒性毒株的动物有很强的先天免疫反应(尽管不像感染丙型肝炎病毒的黑猩猩那样强),而在减毒感染中,这种反应不那么明显。有趣的是,先天免疫反应在后一种黑猩猩中被缩短了,但是对先天免疫反应的检测几乎和对甲型肝炎感染的特定血清学或分子探针的检测一样敏感。适应性免疫反应也存在,但不像黑猩猩感染HCV时的适应性免疫反应那么强。寻找可能阻断其中一些系统的病毒控制机制将是重要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert H. Purcell其他文献

A human parvovirus-like virus inhibits haematopoietic colony formation in vitro
一种类似人类细小病毒的病毒在体外抑制造血集落形成
  • DOI:
    10.1038/302426a0
  • 发表时间:
    1983-03-31
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Philip P. Mortimer;R. Keith Humphries;Jeffrey G. Moore;Robert H. Purcell;Neal S. Young
  • 通讯作者:
    Neal S. Young
Antibody to hepatitis A antigen in children
  • DOI:
    10.1016/s0022-3476(77)81317-6
  • 发表时间:
    1977-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Cladd E. Stevens;Charles E. Cherubin;Jules L. Dienstag;Robert H. Purcell;Wolf Szmuness
  • 通讯作者:
    Wolf Szmuness
Serial transmission in rhesus monkeys of an agent related to hepatitis-associated antigen.
与肝炎相关抗原相关的物质在恒河猴中连续传播。
  • DOI:
    10.1093/infdis/125.4.382
  • 发表时间:
    1972
  • 期刊:
  • 影响因子:
    0
  • 作者:
    W. T. London;H. J. Alter;Jerrold Lander;Robert H. Purcell
  • 通讯作者:
    Robert H. Purcell
Characterization of antibodies to the structural polypeptides of HGSAg: evidence for subtype-specific determinants.
HGSAg 结构多肽抗体的表征:亚型特异性决定因素的证据。
  • DOI:
  • 发表时间:
    1976
  • 期刊:
  • 影响因子:
    4.4
  • 作者:
    Jon W. M. Gold;J.W.K. Shih;Robert H. Purcell;J. Gerin
  • 通讯作者:
    J. Gerin
Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase.
编码衣壳蛋白和 RNA 聚合酶的甲型肝炎病毒 cDNA 的序列分析。

Robert H. Purcell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert H. Purcell', 18)}}的其他基金

Molecular Biology Of Hepatitis C Virus
丙型肝炎病毒的分子生物学
  • 批准号:
    6503690
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
MOLECULAR BIOLOGY OF HEPATITIS C VIRUS
丙型肝炎病毒的分子生物学
  • 批准号:
    6431596
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Pathogenesis Of Viral Hepatitis
病毒性肝炎的发病机制
  • 批准号:
    6987075
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    6985036
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    8555744
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    7592131
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
New Approaches To Passive Immunoprophylaxis
被动免疫预防的新方法
  • 批准号:
    8336238
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    8336037
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
Search For New and Emerging Etiologic Agents
寻找新的和正在出现的病原体
  • 批准号:
    7299912
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:
New Approaches To Passive Immunoprophylaxis
被动免疫预防的新方法
  • 批准号:
    7964628
  • 财政年份:
  • 资助金额:
    $ 104.08万
  • 项目类别:

相似海外基金

Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
  • 批准号:
    MR/Z503605/1
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
  • 批准号:
    2336167
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
  • 批准号:
    2402691
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Standard Grant
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
  • 批准号:
    2341428
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
  • 批准号:
    24K12150
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
  • 批准号:
    DE240100561
  • 财政年份:
    2024
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI: Evaluation of Neurotrophic-Like properties of Spaetzle-Toll Signaling in the Developing and Adult Cricket CNS
RUI:评估发育中和成年蟋蟀中枢神经系统中 Spaetzle-Toll 信号传导的神经营养样特性
  • 批准号:
    2230829
  • 财政年份:
    2023
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Standard Grant
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
  • 批准号:
    23K09542
  • 财政年份:
    2023
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
  • 批准号:
    23K07552
  • 财政年份:
    2023
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
  • 批准号:
    23K07559
  • 财政年份:
    2023
  • 资助金额:
    $ 104.08万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了